Rapid Antidepressant Actions of Scopolamine: Role of Medial Prefrontal Cortex and M1-subtype Muscarinic Acetylcholine Receptors

Clinical studies demonstrate that scopolamine, a nonselective muscarinic acetycholine receptor (mAchR) antagonist, produces rapid therapeutic effects in depressed patients, and preclinical studies report that the actions of scopolamine require glutamate receptor activation and the mechanistic target...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Neurobiol Dis
Main Authors: Navarria, Andrea, Wohleb, Eric S., Voleti, Bhavya, Ota, Kristie T., Dutheil, Sophie, Lepack, Ashley E., Dwyer, Jason M., Fuchikami, Manabu, Becker, Astrid, Drago, Filippo, Duman, Ronald S.
Formato: Artigo
Idioma:Inglês
Publicado em: 2015
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4640941/
https://ncbi.nlm.nih.gov/pubmed/26102021
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.nbd.2015.06.012
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados